Today March 28 the Swedish market close at 13.00. Danish and Norweigan markets is closed.

EQL Pharma is a pharmaceutical company. Currently, the focus is on development of niche and specialised pharmaceuticals, including everything from pharma for the treatment of diabetes, enlargement of blood vessels, as well as various infections and allergies. Primarily business is found in the Nordic market. EQL Pharma was founded in 2006 and is based in Lund.

Quotes for EQL Pharma AB

Right Now

+/-
0.3
%
0,71%
Latest
42.3
High
42.8
Low
42
Volume
26 152
Turnover (SEK)
1 104 058
Market Value (MSEK)
1 229,4
Time (Latest trade)

Board

CEO

  • Axel Schörling

Chairperson of the Board

  • Christer Fåhraeus

Board

  • Anders Månsson
  • Christer Fåhraeus
  • Linda Neckmar
  • Per Ollermark
  • Per Svangren
  • Rajiv I. Modi

Videos

Largest Owners

Name Capital % Votes % Date
Cadila Pharmaceuticals Ltd 30,00 30,00 2023-12-27
Christer Fåhraeus 24,21 24,21 2023-12-27
SEB Fonder 4,25 4,25 2023-12-27
Avanza Pension 3,52 3,52 2023-12-27
Consensus Asset Management 2,79 2,79 2024-02-29
Nordnet Pensionsförsäkring 1,91 1,91 2023-12-27
Sten Irwe 1,65 1,65 2023-12-27
Carnegie Fonder 1,51 1,51 2024-02-29
Cliens Fonder 1,06 1,06 2023-12-27
Lars Fåhraeus 1,05 1,05 2023-12-27
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream